AUTO-PLTS: THE EFFECTIVENESS OF AUTOLOGOUS, COLD-STORED PLATELETS COLLECTED 7-10 DAYS BEFORE CARDI-AC SURGERY FOR AVOIDANCE OF ALLOGENEIC TRANSFUSIONS: A RANDOMIZED PATIENT PREFERENCE TRIAL

Registry ID

24-5285

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

DR. KEYVAN KARKOUTI

Start date

2026-05-13

Last update

2025-02-07

Conditions

• CARDIAC SURGERY

Related clinical trials

• A PHASE 2B, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL GROUP DOSE-FINDING CLINICAL STUDY TO EVALUATE THE EFFICACY ON RENAL FUNCTION, AND SAFETY, OF RMC-035 IN PARTICIPANTS AT HIGH RISK FOR KIDNEY INJURY FOLLOWING OPEN-CHEST CARDIAC SURGERY
• A RANDOMIZED, MULTI-CENTRIC, PLACEBO-CONTROLLED, PARTICIPANT AND INVESTIGATOR-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF TIN816 IN ADULT PATIENTS AT RISK FOR ACUTE KIDNEY INJURY FOLLOWING CARDIAC SURGERY
• ARTEMIS: RAVULIZUMAB TO PROTECT PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) FROM CARDIAC SURGERY ASSOCIATED ACUTE KIDNEY INJURY (CSA-AKI) AND SUBSEQUENT MAJOR ADVERSE KIDNEY EVENTS (MAKE): A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY
• FACTOR REPLACEMENT IN SURGERY - FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE VERSUS FROZEN PLASMA IN BLEEDING ADULT CARDIAC SURGICAL PATIENTS (¿FARES-II¿ STUDY)
• A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ADAPTIVE, PARALLEL GROUP CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RMC-035 IN SUBJECTS AT HIGH RISK FOR ACUTE KIDNEY INJURY FOLLOWING OPEN-CHEST CARDIAC SURGERY
• A PHASE 2, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BOTULINUM TOXIN TYPE A (AGN-151607) INJECTIONS INTO THE EPICARDIAL FAT PADS TO PREVENT POST-OPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING OPEN-CHEST CARDIAC SURGERY

View on source registry